Polypharmacy Mortality Clusters Cannot Isolate a Benzodiazepine Effect

Written by

in

An English aging study associated one medication pattern with mortality, but that pattern included several drug classes.

What the source reports

The investigators grouped 1,356 older adults with at least five long-term medications into prescribing clusters. A mental-health-drug cluster had higher all-cause and cardiovascular mortality than a CNS-drug reference cluster. Antidepressants predominated in that cluster; benzodiazepines, opioids, and muscle relaxants were also represented.

Limits of the evidence

Medication data were collected at one point and did not fully specify dose, duration, or frequency. Cluster comparisons do not separate effects of individual drugs from the conditions for which they were prescribed. The reference category also matters to the estimate.

Implications for forensic review

An expert should not quote the cluster hazard ratio as a benzodiazepine-specific death risk. The appropriate use is to examine combined medication burden and underlying illness. For an individual causation opinion, actual exposure timing and clinical evidence remain essential.

Source and related reading

Source reviewed: The impact of high risk medications on mortality risk among older adults with polypharmacy evidence (PMC8675465). This article summarizes the supplied paper; forensic applications above are interpretive analysis.

Related reading: A Mixed Midazolam–Propofol Comparison Cannot Identify Midazolam’s Independent Mortality Effect; Five-Year Mortality Association Cannot Serve as an Acute Benzodiazepine Lethality Estimate.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *